Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
12
|
| pubmed:dateCreated |
1998-1-23
|
| pubmed:abstractText |
Drug treatment of high blood pressure has been shown to reduce the associated cardiovascular risk. Stroke represents the type of event more strongly linked with high blood pressure, responsible for a high rate of death or invalidity, and with the highest proportion of events that can be avoided by treatment. Hypertensive patients with a history of cerebrovascular accident are at particularly high risk of recurrence. Specific trials of blood pressure lowering drugs in stroke survivors showed inconclusive results in the past.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0039-2499
|
| pubmed:author |
pubmed-author:BoisselJ PJP,
pubmed-author:BoutitieFF,
pubmed-author:CoopeJJ,
pubmed-author:CutlerJJ,
pubmed-author:EkbomTT,
pubmed-author:FagardRR,
pubmed-author:FriedmanLL,
pubmed-author:GueyffierFF,
pubmed-author:KerlikowskeKK,
pubmed-author:PerryMM,
pubmed-author:PocockSS,
pubmed-author:PrineasRR,
pubmed-author:SchronEE
|
| pubmed:issnType |
Print
|
| pubmed:volume |
28
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2557-62
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9412649-Aged,
pubmed-meshheading:9412649-Antihypertensive Agents,
pubmed-meshheading:9412649-Cerebrovascular Disorders,
pubmed-meshheading:9412649-Clinical Trials as Topic,
pubmed-meshheading:9412649-Female,
pubmed-meshheading:9412649-Humans,
pubmed-meshheading:9412649-Hypertension,
pubmed-meshheading:9412649-Male,
pubmed-meshheading:9412649-Middle Aged,
pubmed-meshheading:9412649-Recurrence
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators.
|
| pubmed:affiliation |
Clinical Pharmacology Department, Claude Bernard University, Lyon Hospitals, France. fg@upcl.univ-lyon1.fr
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|